Endocrine Society
4350 East West Highway, Suite 500
Bethesda
Maryland
20814-4410
United States
Tel: 301-941-0200
Fax: 301-941-0259
Website: http://www.endo-society.org/
Email: endostaff@endo-society.org
36 articles about Endocrine Society
-
Endocrine Society Opens Nominations For Inaugural Baxter Prize
7/26/2017
-
Novelion Release: Metreleptin And Lipodystrophy Data Presented At The Annual Meeting Of The Endocrine Society
4/5/2017
-
Marina Biotech To Present Data On Vascular Resistance And Cancer At Endocrine Society Annual Meeting On April 1
3/27/2017
-
Endocrine Society Launches First Open Access Journal
1/13/2017
-
Endocrine Society Celebrates 100 Years Of Public Health Breakthroughs
1/21/2016
-
Versartis, Inc. Presents 12-Month Data For VRS-317 At Late-Breaker Session At Endocrine Society's Annual Meeting
3/9/2015
-
Trimel Pharmaceuticals Announces Natesto Abstract Presentation At The 2015 Endocrine Society Annual Meeting
3/9/2015
-
Corcept Therapeutics Announces Nine Poster Presentations On Mifepristone For The Treatment Of Cushing's Syndrome At The 97th Annual Corcept Therapeutics Inc. Meeting
3/6/2015
-
Eisai Inc. Release: Survey Presented At The Joint Annual Meeting Of The International Congress Of Endocrinology And The Endocrine Society (ICE/ENDO 2014) Shows Most Of Those Affected By Obesity Are Not Taking Steps To Lose Weight
6/23/2014
-
NPS Pharmaceuticals, Inc. to Present Data from Natpara™ REPLACE Study and PARADOX Study at ENDO 2013, the Endocrine Society’s 95th Annual Meeting
6/5/2013
-
The Ezra Company Negotiates Strong Deal for the Endocrine Society in Its Purchase of 34,000 Square Feet at 2055 L St. NW in Washington, D.C.
5/28/2013
-
TherapeuticsMD, Inc. Announces Plans in Hormone Therapy That Concur With the Recent Joint Statement from NAMS, ASRM and The Endocrine Society
7/10/2012
-
Radius Announces Upcoming Scientific Presentations at ENDO 2012, the Endocrine Society's 94th Annual Meeting
6/22/2012
-
Experts Find Continuous Glucose Monitoring Beneficial in Maintaining Target Blood Glucose Levels, Endocrine Society Reveals
10/12/2011
-
Versartis, Inc. Long-Term Preclinical Safety Data for VRS-317 Presented at Endocrine Society 2011
6/6/2011
-
Ligand Pharmaceuticals Inc. Presents Multi-Dose Phase I Data on Lead SARM Molecule LGD-4033 at the Endocrine Society Annual Meeting
6/6/2011
-
Corcept Therapeutics Inc. Announces Conference Call to Discuss Detailed Findings From Corlux Phase 3 Trial in Cushing's Syndrome at the Endocrine Society's Annual Meeting
6/1/2011
-
Corcept Therapeutics Inc. to Present Detailed Findings From CORLUX Phase 3 Trial in Cushing's Syndrome at the Endocrine Society's Annual Meeting, June 4-7
5/19/2011
-
Endocrine Society's Annual Meeting to Feature Data on Endocrine Society's Qnexa
6/17/2010
-
Aegis Therapeutics, LLC's First Orally Bioavailable Anti-Obesity/Diabetes Peptide Drug Candidate to Be Presented at the Aegis Therapeutics, LLC Annual Meeting in San Diego, June 19-22, 2010
5/13/2010